Avid Bioservices Presents Data from Manufacturing Successes Achieved with Single-Use Bioreactor Systems

TUSTIN, Calif. and SAN FRANCISCO, March 16 /PRNewswire/ -- Avid Bioservices, Inc. today presented data highlighting the comparability of production run performance between the company's single-use bioreactors (Thermo Scientific HyClone S.U.B.) and its traditional stainless steel bioreactors at the Thermo Scientific BioProduction Optimization Workshop in San Francisco, California. The presentation included cell culture performance data comparing multiple stainless steel and S.U.B. production runs at the 1000-liter scale in the company's cGMP manufacturing facility in Tustin, CA.

"Our HyClone S.U.B. system provides important consistency, scalability and efficiencies in our cGMP biomanufacturing services," said Richard Richieri, Avid's senior vice president, technical operations. "Data from both the 1000 and 100 liter S.U.B. show our process is consistent and scalable, allowing us considerable flexibility to manufacture products using either the S.U.B. or traditional stainless steel bioreactor systems to meet our clients' clinical trial materials requirements. The manufacturing efficiencies from using our S.U.B., including reduced changeover time between manufacturing runs and shortened project timelines, are critical as we support our clients' clinical and commercial production needs."

About the Thermo Scientific HyClone S.U.B.

The Thermo Scientific HyClone S.U.B. consists of a reusable stainless steel outer support container and S.U.B. BioProcess Container (BPC®) that integrates with existing bioreactor control systems, providing the advantages of single-use bioprocessing without having to install a complete new bioreactor system. The retrofit product replaces the stainless steel bioreactor vessel in existing bioreactor systems, making it a flexible, rapid and economic option to increase bioreactor capacity.

About Avid Bioservices

Avid Bioservices provides a comprehensive range of cGMP manufacturing services for the biotechnology and biopharmaceutical industries. Avid manufactures cGMP commercial product, as well as clinical supplies for all phases of clinical trials. The company's comprehensive range of cGMP services includes cell banking, stability testing, clinical and commercial product manufacturing and purification, bulk packaging, final product filling and regulatory support. Avid also provides a variety of process development activities, including cell line optimization, analytical method development and product characterization. The company has over 10 years of antibody manufacturing experience producing monoclonal antibodies and recombinant proteins in batch, fed-batch and perfusion modes. For more information about Avid, visit www.avidbio.com.

Avid Bioservices is a wholly owned subsidiary of Peregrine Pharmaceuticals Inc.

SOURCE Avid Bioservices, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED